Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...

At Retina Society 2026, Emily Eton, MD, discusses a 10-center study finding similar exudate control in Coats disease and ...

“Our findings demonstrate that a simple oral pill can effectively target and repair the inner blood-retina barrier. This ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr Dao Nguyen examines a vial of lutein formulation developed for potential use in eyedrop treatments. (CREDIT: Will Wright, RMIT ...

Patients with neovascular age‑related macular degeneration (AMD) whose retinal fluid cleared within 12 weeks of starting faricimab were more likely to have longer intervals between injections later in ...

D-150 is advancing into Phase 3 development for DME, a second multi-billion-dollar retinal disease market with significant unmet need  First patients have been enrolled in 4SIGHT global Phase 3 trial ...

D Molecular Therapeutics remains a Buy as 4D-150 enters phase 3 for wet AMD/DME, cutting injections up to 87%. Click for more ...

The demise of a copay assistance program for people who receive eye injections for retinal diseases has disproportionately raised out-of-pocket costs for lower-income patients and those on fixed ...

Clearside Biomedical, Inc. has announced that its suprachoroidal injection delivery platform will be prominently featured at the Clinical Trials at the Summit (CTS) Meeting on June 21, 2025, in Las ...

The RC28-E intravitreal injection is a dual-target fusion protein aimed at treating retinal diseases. Credit: Sai Thaw Kyar/Shutterstock.com. · Pharmaceutical Technology · Sai Thaw ...

CHICAGO -- Retinal injections for eye disease had a significant association with increased complications rates after cataract surgery, according to a large retrospective cohort study. Seven different ...